October 29, 2026For those who have memorized EEG waveforms but get confused by similar options in nerve conduction studies ...

A critical narrative review of over 160 studies finds quantitative EEG useful for longitudinal epilepsy treatment monitoring ...

Full year 2026 revenue guidance was narrowed to $115 million to $117 million, which notably excludes material contributions ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company developing first-in-class synaptic regenerative and corrective therapeutics, today announced it has been awarded "Regenerative Therapeutics ...

CeriBell reported third quarter 2026 revenue of US$29.34 million and a net loss of US$21.35 million, and raised full year ...

Published research includes a 12-week pilot in which adults with chronic shoulder or low-back pain reported a 3.5-point mean ...

A scoping review of 93 studies finds that commercial processed EEG indices such as BIS correlate strongly but imperfectly ...

Independent validation of AON’s quality and patient safety standards supports continued growth in at-home and inpatient ...

A newly FDA-cleared PTSD treatment achieved a 68% remission rate and a 52% average reduction in symptoms during a clinical ...

Autoimmune EncephalitisNeurologyLab Interpretation Autoimmune encephalitis diagnosis combines the symptom pattern, spinal fluid testing, MRI and EEG while excluding infections and other causes. Blood ...

On Wednesday, Enveric Biosciences Inc. ENVB, a biotechnology firm developing neuroplastogenic small-molecule therapeutics for ...